Watson Rebecca’s Colgate-Palmolive CL Stock Holding History

Watson Rebecca’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-70	Closed	-$5K	–	128
2020 Q2	$5K	Buy	+70	New	+$4.97K	﹤0.01%	295

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Watson Rebecca's CL Position: Q3 2020 in Review

Watson Rebecca sold out of Colgate-Palmolive (CL) in Q3 2020, closing a stake of 70 shares — an estimated $5K sold.

Watson Rebecca first reported a position in CL in Q2 2020 and held it in 1 quarter. The position peaked at $5K in Q2 2020. 1,531 funds tracked by Wall St. Rank hold CL as of Q3 2020.

Watson Rebecca reported no remaining Colgate-Palmolive position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 70 Colgate-Palmolive shares in Q3 2020, an estimated $5K.
Watson Rebecca first reported a position in Colgate-Palmolive in Q2 2020 and held it in 1 quarter.
Watson Rebecca's Colgate-Palmolive position peaked at $5K in Q2 2020.
1,531 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.